BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨

路透中文

Mar 19

BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨

3月19日 - ** 医疗设备制造商Embecta EMBC.O的股价盘前上涨2%至8.99美元

** 该公司称将收购私营企业Owen Mumford，交易价值高达1.5亿英镑(1.991亿美元)，将业务扩展到糖尿病以外的给药设备领域。

** 公司将预付 1亿英镑现金，其中 5000万英镑与欧文-芒福德的 Aidaptus 自动注射器平台三年内的销售额挂钩 - EMBC

** 公司表示，欧文-芒福德公司生产自动注射器和自我注射设备，用于为肥胖症、自身免疫性疾病和过敏症等疾病提供治疗药物

** 称该交易将有助于实现收入多元化，并利用其全球销售网络支持增长

** 交易预计将于 2026 财年第三季度完成，但需获得监管部门批准；交易资金来自借款 - EMBC

** 2025 年股价下跌 ~42%

(1 美元 = 0.7534 英镑)

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2620241129"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620241129\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620241129?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-19 18:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620241129","market":"hk","top_or_hot":-1,"title":"BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨</title></head><body><p><span>3月19日</span><span> - </span>** 医疗设备制造商Embecta <span>EMBC.O</span>的股价盘前上涨2%至8.99美元</p><p>** 该公司称将收购私营企业Owen Mumford，交易价值高达1.5<span>亿英镑(1.991亿美元)</span>，将业务扩展到糖尿病以外的给药设备领域。</p><p>** 公司将预付 1<span>亿英镑 </span>现金，其中 5000<span>万英镑</span>与欧文-芒福德的 Aidaptus 自动注射器平台三年内的销售额挂钩 - EMBC</p><p>** 公司表示，欧文-芒福德公司生产自动注射器和自我注射设备，用于为肥胖症、自身免疫性疾病和过敏症等疾病提供治疗药物</p><p>** 称该交易将有助于实现收入多元化，并利用其全球销售网络支持增长</p><p>** 交易预计将于 2026 财年第三季度完成，但需获得监管部门批准；交易资金来自借款 - EMBC</p><p>** 2025 年股价下跌 ~42%</p><p>(1 美元 = 0.7534 英镑)</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-03-19 18:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨</title></head><body><p><span>3月19日</span><span> - </span>** 医疗设备制造商Embecta <span>EMBC.O</span>的股价盘前上涨2%至8.99美元</p><p>** 该公司称将收购私营企业Owen Mumford，交易价值高达1.5<span>亿英镑(1.991亿美元)</span>，将业务扩展到糖尿病以外的给药设备领域。</p><p>** 公司将预付 1<span>亿英镑 </span>现金，其中 5000<span>万英镑</span>与欧文-芒福德的 Aidaptus 自动注射器平台三年内的销售额挂钩 - EMBC</p><p>** 公司表示，欧文-芒福德公司生产自动注射器和自我注射设备，用于为肥胖症、自身免疫性疾病和过敏症等疾病提供治疗药物</p><p>** 称该交易将有助于实现收入多元化，并利用其全球销售网络支持增长</p><p>** 交易预计将于 2026 财年第三季度完成，但需获得监管部门批准；交易资金来自借款 - EMBC</p><p>** 2025 年股价下跌 ~42%</p><p>(1 美元 = 0.7534 英镑)</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nL4S40713A:1","article_id":"2620241129","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620241129","pubTimestamp":1773917440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Embecta同意收购英国设备制造商欧文-芒福德后股价上涨3月19日 - ** 医疗设备制造商Embecta EMBC.O的股价盘前上涨2%至8.99美元** 该公司称将收购私营企业Owen Mumford，交易价值高达1.5亿英镑，将业务扩展到糖尿病以外的给药设备领域。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4198":"医疗保健用品","EMBC":"Embecta Corp."},"translate_title":"BUZZ-Embecta shares rise after agreeing to buy British equipment maker Owen Mumford","themeId":"37684715aaf54a73b9fe52ee56a263cc","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMBC":0.9},"content_text":"BUZZ-Embecta同意收购英国设备制造商欧文-芒福德（Owen Mumford）后股价上涨3月19日 - ** 医疗设备制造商Embecta EMBC.O的股价盘前上涨2%至8.99美元** 该公司称将收购私营企业Owen Mumford，交易价值高达1.5亿英镑(1.991亿美元)，将业务扩展到糖尿病以外的给药设备领域。** 公司将预付 1亿英镑 现金，其中 5000万英镑与欧文-芒福德的 Aidaptus 自动注射器平台三年内的销售额挂钩 - EMBC** 公司表示，欧文-芒福德公司生产自动注射器和自我注射设备，用于为肥胖症、自身免疫性疾病和过敏症等疾病提供治疗药物** 称该交易将有助于实现收入多元化，并利用其全球销售网络支持增长** 交易预计将于 2026 财年第三季度完成，但需获得监管部门批准；交易资金来自借款 - EMBC** 2025 年股价下跌 ~42%(1 美元 = 0.7534 英镑)(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}